Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 476,124 | 299,521 | 394,796 | 389,578 | 409,195 |
| Receivables | 2,526 | 2,599 | 3,094 | 3,164 | 3,051 |
| Other current assets | 43,725 | 41,495 | 40,247 | 17,780 | 18,774 |
| TOTAL | $522,375 | $343,615 | $438,137 | $410,522 | $431,020 |
| Non-Current Assets | |||||
| PPE Net | 83,633 | 86,716 | 86,510 | 86,248 | 89,768 |
| Intangibles | 90,266 | 85,132 | 88,499 | 92,209 | 103,273 |
| Other Non-Current Assets | 79,587 | 42,384 | 40,553 | 41,846 | 42,638 |
| TOTAL | $253,486 | $214,232 | $215,562 | $220,303 | $235,679 |
| Total Assets | $775,861 | $557,847 | $653,699 | $630,825 | $666,699 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,762 | 5,115 | 3,953 | 4,265 | 2,086 |
| Accrued Expenses | 33,401 | 26,070 | 46,635 | 39,806 | 32,873 |
| Other current liabilities | 32,204 | 36,618 | 36,426 | 43,997 | 73,105 |
| TOTAL | $86,083 | $73,920 | $93,171 | $94,118 | $113,959 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,921 | 1,071 | 1,101 | 1,126 | 1,155 |
| Other Non-Current Liabilities | 82,408 | 81,177 | 94,652 | 95,683 | 78,286 |
| TOTAL | $105,329 | $82,776 | $97,092 | $98,740 | $83,777 |
| Total Liabilities | $191,412 | $156,696 | $190,263 | $192,858 | $197,736 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 281,109 | 237,664 | 234,653 | 216,623 | 215,588 |
| Common Shares | 3 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,156,535 | -1,058,995 | -967,622 | -874,626 | -781,609 |
| TOTAL | $584,449 | $401,151 | $463,436 | $437,967 | $468,963 |
| Total Liabilities And Equity | $775,861 | $557,847 | $653,699 | $630,825 | $666,699 |